SCHEMBL10263247

SCHEMBL10263247

Cc1nc(-c2cccc(F)c2)co1

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ENPP3 O14638 5/20 0.59
SCN9A Q15858 1/20 0.53
ENPP1 P22413 3/20 0.51
KMT2A Q03164 3/20 0.47
KDM4E B2RXH2 2/20 0.46
MEN1 O00255 2/20 0.46
MAPT P10636 1/20 0.46
NOTUM Q6P988 1/20 0.44
IDO1 P14902 1/20 0.44
PIM1 P11309 1/20 0.41
ALDH1A1 P00352 1/20 0.41
PKM P14618 1/20 0.41
BCHE P06276 1/20 0.41
ACHE P22303 1/20 0.41
MGAM O43451 1/20 0.41
GAA P10253 1/20 0.41
SI P14410 1/20 0.41
MGAM2 Q2M2H8 1/20 0.41
KMO O15229 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10263343 0.82 ENPP3 (0.84) ENPP3SCN9AENPP1KMT2AKDM4E
SCHEMBL14564372 0.81 ENPP3 (0.71) ENPP3SCN9AENPP1KMT2AMEN1
SCHEMBL9954331 0.79 KDM4E (0.50) KMT2AKDM4EMEN1MAPTNOTUM
SCHEMBL8418313 0.79 ENPP3 (0.56) ENPP3SCN9AENPP1KMT2AMEN1
SCHEMBL3318051 0.79 ENPP3 (0.59) ENPP3SCN9AENPP1
SCHEMBL10263341 0.79 ENPP3 (0.59) ENPP3SCN9AENPP1KMT2AMEN1
SCHEMBL28702905 0.79 KDM4E (0.46) KMT2AKDM4EMEN1MAPTNOTUM
SCHEMBL16531906 0.79 ENPP3 (0.59) ENPP3SCN9AENPP1KMT2AMEN1
SCHEMBL12021956 0.79 ENPP3 (0.59) ENPP3SCN9AENPP1KMT2AKDM4E
SCHEMBL6986241 0.78 ENPP3 (0.69) ENPP3SCN9AENPP1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012085857-A1 3,8-DIAZA-BICYCLO[4.2.0]OCT-3-YL AMIDES ACTELION PHARMACEUTICALS LTD (CH) 2012-06-28 WO disclosed
WO-2012085852-A1 3,8-DIAZA-BICYCLO[4.2.0]OCT-8-YL AMIDES ACTELION PHARMACEUTICALS LTD (CH) 2012-06-28 WO disclosed